These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17478129)

  • 1. NMR solution structure of the angiostatic peptide anginex.
    Arroyo MM; Mayo KH
    Biochim Biophys Acta; 2007 May; 1774(5):645-51. PubMed ID: 17478129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide.
    Dings RP; Arroyo MM; Lockwood NA; van Eijk LI; Haseman JR; Griffioen AW; Mayo KH
    Biochem J; 2003 Jul; 373(Pt 1):281-8. PubMed ID: 12708970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foldameric α/β-peptide analogs of the β-sheet-forming antiangiogenic anginex: structure and bioactivity.
    Hegedüs Z; Wéber E; Kriston-Pál É; Makra I; Czibula Á; Monostori É; Martinek TA
    J Am Chem Soc; 2013 Nov; 135(44):16578-84. PubMed ID: 24088182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity.
    Mayo KH; Dings RP; Flader C; Nesmelova I; Hargittai B; van der Schaft DW; van Eijk LI; Walek D; Haseman J; Hoye TR; Griffioen AW
    J Biol Chem; 2003 Nov; 278(46):45746-52. PubMed ID: 12947097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing structure-activity relationships in bactericidal peptide betapep-25.
    Dings RP; Haseman JR; Mayo KH
    Biochem J; 2008 Aug; 414(1):143-50. PubMed ID: 18489259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anginex, a designed peptide that inhibits angiogenesis.
    Griffioen AW; van der Schaft DW; Barendsz-Janson AF; Cox A; Struijker Boudier HA; Hillen HF; Mayo KH
    Biochem J; 2001 Mar; 354(Pt 2):233-42. PubMed ID: 11171099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A folding pathway for betapep-4 peptide 33mer: from unfolded monomers and beta-sheet sandwich dimers to well-structured tetramers.
    Mayo KH; Ilyina E
    Protein Sci; 1998 Feb; 7(2):358-68. PubMed ID: 9521112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.
    Wang JB; Wang MD; Li EX; Dong DF
    Peptides; 2012 Dec; 38(2):457-62. PubMed ID: 22985857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR structure of a de novo designed, peptide 33mer with two distinct, compact beta-sheet folds.
    Ilyina E; Roongta V; Mayo KH
    Biochemistry; 1997 Apr; 36(17):5245-50. PubMed ID: 9136886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and NMR conformational study of a beta-sheet peptide based on Betanova and WW domains.
    Fernández-Escamilla AM; Ventura S; Serrano L; Jiménez MA
    Protein Sci; 2006 Oct; 15(10):2278-89. PubMed ID: 16963647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-angiogenic peptide anginex disrupts the cell membrane.
    Pilch J; Franzin CM; Knowles LM; Ferrer FJ; Marassi FM; Ruoslahti E
    J Mol Biol; 2006 Mar; 356(4):876-85. PubMed ID: 16403516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein.
    Brandwijk RJ; Nesmelova I; Dings RP; Mayo KH; Thijssen VL; Griffioen AW
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1261-8. PubMed ID: 15979575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solution structure of the domain from MeCP2 that binds to methylated DNA.
    Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
    J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR solution structure of a peptide from the mdm-2 binding domain of the p53 protein that is selectively cytotoxic to cancer cells.
    Rosal R; Pincus MR; Brandt-Rauf PW; Fine RL; Michl J; Wang H
    Biochemistry; 2004 Feb; 43(7):1854-61. PubMed ID: 14967026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anginex-conjugated liposomes for targeting of angiogenic endothelial cells.
    Brandwijk RJ; Mulder WJ; Nicolay K; Mayo KH; Thijssen VL; Griffioen AW
    Bioconjug Chem; 2007; 18(3):785-90. PubMed ID: 17378601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR solution structure of the archaebacterial chromosomal protein MC1 reveals a new protein fold.
    Paquet F; Culard F; Barbault F; Maurizot JC; Lancelot G
    Biochemistry; 2004 Nov; 43(47):14971-8. PubMed ID: 15554704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the calcium channel antagonist omega-conotoxin GVIA.
    Skalicky JJ; Metzler WJ; Ciesla DJ; Galdes A; Pardi A
    Protein Sci; 1993 Oct; 2(10):1591-603. PubMed ID: 8251934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex assembly mechanism and an RNA-binding mode of the human p14-SF3b155 spliceosomal protein complex identified by NMR solution structure and functional analyses.
    Kuwasako K; Dohmae N; Inoue M; Shirouzu M; Taguchi S; Güntert P; Séraphin B; Muto Y; Yokoyama S
    Proteins; 2008 Jun; 71(4):1617-36. PubMed ID: 18076038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A journey in structure-based drug discovery: from designed peptides to protein surface topomimetics as antibiotic and antiangiogenic agents.
    Dings RP; Mayo KH
    Acc Chem Res; 2007 Oct; 40(10):1057-65. PubMed ID: 17661438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.